D. Ogg

1.8k citations

23 papers · 990 indexed · h-index 16

Impact in

Endocrinology top 5%
- Escherichia coli research studies
Molecular Biology
- Fibroblast Growth Factor Research
- Protein Tyrosine Phosphatases
- RNA and protein synthesis mechanisms
- Microbial metabolism and enzyme function

Papers in ⓘ

Toxicology 2
Biochemistry 4

Co-authors: Jan Kihlberg (2 shared papers)Scott J. Hultgren (2 shared papers)Meta Kuehn (1 shared paper)Terese Bergfors (1 shared paper)Scott D. Larsen (2 shared papers)Barbara J. Palazuk (2 shared papers)John E. Bleasdale (2 shared papers)Charlotta Liljebris (2 shared papers)
Journals: Journal of Medicinal Chemistry (6 papers)MedChemComm (2 papers)Acta Crystallographica Section D Structural Biology (1 paper)Journal of the American Chemical Society (1 paper)FEBS Letters (1 paper)
Partner nations: United Kingdom Sweden United States

In The Last Decade

D. Ogg

23 papers receiving 962 citations

Peers

Countries citing papers authored by D. Ogg

Since Specialization

Citations

This map shows the geographic impact of D. Ogg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Ogg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Ogg more than expected).

Fields of papers citing papers by D. Ogg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Ogg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Ogg. The network helps show where D. Ogg may publish in the future.

Co-authors

The 25 scholars most cited alongside D. Ogg, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with D. Ogg Line = papers co-authored together D. Ogg links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Structural Basis of Pilus Subunit Recognition by the PaPd Chaperone Science ·Meta Kuehn, D. Ogg, Jan Kihlberg, Lynn N. Slonim, Katarina Flemmer, Terese Bergfors, Scott J. Hultgren	1993	175
2	Landscape of activating cancer mutations in FGFR kinases and their differential responses to inhibitors in clinical use Oncotarget ·Harshnira Hitesh Patani, Tom D. Bunney, Nethaji Thiyagarajan, Richard A. Norman, D. Ogg, J. Breed, Paul Ashford, Andrew Potterton, Mina Edwards, Sarah V. Williams, Gary S. Thomson, Camilla Pang, Margaret A. Knowles, Alexander L. Breeze, Christine Orengo, Chris Phillips, Matilda Katan	2016	91
3	Investigation of Potential Bioisosteric Replacements for the Carboxyl Groups of Peptidomimetic Inhibitors of Protein Tyrosine Phosphatase 1B: Identification of a Tetrazole-Containing Inhibitor with Cellular Activity Journal of Medicinal Chemistry ·Charlotta Liljebris, Scott D. Larsen, D. Ogg, Barbara J. Palazuk, John E. Bleasdale	2002	85
4	The structure of mouse L1210 dihydrofolate reductase‐drug complexes and the construction of a model of human enzyme FEBS Letters ·D.K. Stammers, J.N. Champness, C.R. Beddell, John G. Dann, Elias Eliopoulos, A. J. Geddes, D. Ogg, A.C.T. North	1987	78
5	Periplasmic chaperone recognition motif of subunits mediates quaternary interactions in the pilus The EMBO Journal ·Gabriel E. Soto, Karen Dodson, D. Ogg, Christopher Liu, John Heuser, Stefan D. Knight, Jan Kihlberg, C. Hal Jones, Scott J. Hultgren	1998	75
6	Structure of human semicarbazide-sensitive amine oxidase/vascular adhesion protein-1 Acta Crystallographica Section D Biological Crystallography ·Emma Jakobsson, Joakim Nilsson, D. Ogg, Gerard J. Kleywegt	2005	60
7	Synthesis and Biological Activity of a Novel Class of Small Molecular Weight Peptidomimetic Competitive Inhibitors of Protein Tyrosine Phosphatase 1B Journal of Medicinal Chemistry ·Scott D. Larsen, Tjeerd Barf, Charlotta Liljebris, Paul D. May, D. Ogg, Theresa J. O’Sullivan, Barbara J. Palazuk, Heinrich J. Schostarez, Frits C. Stevens, John E. Bleasdale	2001	60
8	The structure of human collapsin response mediator protein 2, a regulator of axonal growth Journal of Neurochemistry ·Pål Stenmark, D. Ogg, S. Flodin, Alex F. C. Flores, T. Kotenyova, T. Nyman, P. Nordlund, Petri Kursula	2006	57
9	Alkynyl Benzoxazines and Dihydroquinazolines as Cysteine Targeting Covalent Warheads and Their Application in Identification of Selective Irreversible Kinase Inhibitors Journal of the American Chemical Society ·Kirsten McAulay, Emily Hoyt, Morgan Thomas, Marianne Schimpl, Michael S. Bodnarchuk, Hilary Lewis, Derek Barratt, Deepa Bhavsar, David M. Robinson, Michael J. Deery, D. Ogg, Gonçalo J. L. Bernardes, Richard A. Ward, Michael J. Waring, Jason G. Kettle	2020	57
10	Discovery of a Potent, Selective, and Orally Bioavailable Acidic 11β-Hydroxysteroid Dehydrogenase Type 1 (11β-HSD1) Inhibitor: Discovery of 2-[(3S)-1-[5-(Cyclohexylcarbamoyl)-6-propylsulfanylpyridin-2-yl]-3-piperidyl]acetic Acid (AZD4017) Journal of Medicinal Chemistry ·James S. Scott, Suzanne S. Bowker, Joanne deSchoolmeester, S. Gerhardt, David Hargreaves, Elaine Kilgour, Adele Lloyd, Rachel M. Mayers, William McCoull, Nicholas J. Newcombe, D. Ogg, Martin J. Packer, Amanda Rees, John Revill, Paul N. Schofield, Nidhal Selmi, John G. Swales, Paul R. O. Whittamore	2012	49
11	The Crystal Structure of Guinea Pig 11β-Hydroxysteroid Dehydrogenase Type 1 Provides a Model for Enzyme-Lipid Bilayer Interactions Journal of Biological Chemistry ·D. Ogg, Björn Elleby, Carina Norström, Karin Stefansson, Lars Abrahmsén, Udo Oppermann, Stefan Svensson	2004	39
12	Protein–Ligand Crystal Structures Can Guide the Design of Selective Inhibitors of the FGFR Tyrosine Kinase Journal of Medicinal Chemistry ·Richard A. Norman, Anne-Kathrin Schott, David Andrews, J. Breed, Kevin M. Foote, Andrew P. Garner, D. Ogg, Jonathon P. Orme, Jennifer H. Pink, Karen Roberts, David A. Rudge, Andrew P. Thomas, Andrew G. Leach	2012	36
13	Novel Acidic 11β-Hydroxysteroid Dehydrogenase Type 1 (11β-HSD1) Inhibitor with Reduced Acyl Glucuronide Liability: The Discovery of 4-[4-(2-Adamantylcarbamoyl)-5-tert-butyl-pyrazol-1-yl]benzoic Acid (AZD8329) Journal of Medicinal Chemistry ·James S. Scott, Joanne deSchoolmeester, Elaine Kilgour, Rachel M. Mayers, Martin J. Packer, David Hargreaves, S. Gerhardt, D. Ogg, Amanda Rees, Nidhal Selmi, Andrew Stocker, John G. Swales, Paul R. O. Whittamore	2012	31
14	The structure of the PP2A regulatory subunit B56γ: The remaining piece of the PP2A jigsaw puzzle Proteins Structure Function and Bioinformatics ·A. Magnusdottir, Pål Stenmark, S. Flodin, T. Nyman, T. Kotenyova, S. Gräslund, D. Ogg, P. Nordlund	2008	16
15	Development of Selective Phosphatidylinositol 5-Phosphate 4-Kinase γ Inhibitors with a Non-ATP-competitive, Allosteric Binding Mode Journal of Medicinal Chemistry ·Helen K. Boffey, Timothy P. C. Rooney, Henriëtte M. G. Willems, Simon Edwards, Christopher Green, Tina Howard, D. Ogg, Tamara Romero, Duncan E. Scott, David Winpenny, James A. Duce, John Skidmore, Jonathan H. Clarke, Stephen P. Andrews	2022	16
16	Crystallization of a truncated soluble human semicarbazide-sensitive amine oxidase Acta Crystallographica Section F Structural Biology and Crystallization Communications ·Emma Jakobsson, Joakim Nilsson, Ulla Källström, D. Ogg, Gerard J. Kleywegt	2005	15
17	Discovery of a novel allosteric inhibitor-binding site in ERK5: comparison with the canonical kinase hinge ATP-binding site Acta Crystallographica Section D Structural Biology ·Hongming Chen, Julie A. Tucker, Xiaotao Wang, Paul R. Gavine, Chris Phillips, Martin Augustin, Patrick Schreiner, Stefan Steinbacher, Marian Preston, D. Ogg	2016	13
18	Structures of the hydrolase domain of human 10-formyltetrahydrofolate dehydrogenase and its complex with a substrate analogue Acta Crystallographica Section D Biological Crystallography ·Petri Kursula, H. Schüler, S. Flodin, P. Nilsson-Ehle, D. Ogg, P. Savitsky, P. Nordlund, Pål Stenmark	2006	10
19	Purification and preliminary characterization of phosphoglycerate mutase from Schizosaccharomyces pombe International Journal of Biochemistry ·Nicholas C. Price, Doris Duncan, D. Ogg	1985	10
20	Optimising pharmacokinetics of glucokinase activators with matched triplicate design sets – the discovery of AZD3651 and AZD9485 MedChemComm ·Michael J. Waring, Stuart N. L. Bennett, Scott Boyd, Leonie Campbell, Robert D. M. Davies, David Hargreaves, Philip A. MacFaul, Nathaniel G. Martin, D. Ogg, Graeme R. Robb, Gary Wilkinson, J. Matthew Wood	2013	6

About D. Ogg

D. Ogg is a scholar working on Toxicology, Biochemistry, Pharmacology, Endocrinology, Diabetes and Metabolism and Immunology, having authored 23 papers that have together received 990 indexed citations. Recurring topics across this work include Hormonal Regulation and Hypertension (5 papers), Enzyme Structure and Function (5 papers), Protein Structure and Dynamics (3 papers), Kruppel-like factors research (2 papers), Computational Drug Discovery Methods (2 papers), Protein Tyrosine Phosphatases (2 papers), Galectins and Cancer Biology (2 papers) and Toxin Mechanisms and Immunotoxins (2 papers). The work is most often cited by research in Endocrinology (108 citations), Molecular Biology (673 citations), Biochemistry (67 citations), Cell Biology (125 citations) and Toxicology (21 citations). D. Ogg has collaborated with scholars based in United Kingdom, Sweden and United States. Frequent co-authors include Jan Kihlberg, Scott J. Hultgren, Meta Kuehn, Terese Bergfors, Scott D. Larsen, Barbara J. Palazuk, John E. Bleasdale, Charlotta Liljebris, Emma Jakobsson and Joakim Nilsson. Their work appears in journals such as Journal of Medicinal Chemistry, MedChemComm, Acta Crystallographica Section D Structural Biology, Journal of the American Chemical Society and FEBS Letters.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact